Pacific Biosciences Of California | PACB - Net Income


Pacific Biosciences Of California reported $-40.37M in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
Agilent USD 362M 23M Jun/2026
Bruker USD -122.8M 59.9M Sep/2026
Danaher USD 1.24B 365M Sep/2026
General Electric Aerospace USD 2.29B 82M Sep/2026
Illumina USD 220M 13M Sep/2026
Myriad Genetics USD -7.9M 19.5M Dec/2025
Pacific Biosciences Of California USD -40.37M 2.37M Dec/2025
Quidel USD -53.8M 39.1M Sep/2026
Revvity USD 62.3M 10.48M Sep/2026
Roche Holding CHF 6.87B 1.4B Jun/2026
Standard Biotools USD -26.76M 153.83M Jun/2026
Thermo Fisher Scientific USD 1.72B 15M Sep/2026
Waters USD -136M 64M Jun/2026